(Q36845941)

16 August 2017

Bone resorption inhibitors from hop extract (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

1 reference

Tobe H

1

1 reference

16 August 2017

Muraki Y

2

1 reference

16 August 2017

Kitamura K

3

1 reference

16 August 2017

Komiyama O

4

1 reference

16 August 2017

Sato Y

5

1 reference

16 August 2017

Sugioka T

6

1 reference

16 August 2017

Maruyama HB

7

1 reference

16 August 2017

Matsuda E

8

1 reference

16 August 2017

Nagai M

9

1 reference

16 August 2017

January 1997

1 reference

Crossref

full work available at URL

16 September 2022

https://academic.oup.com/bbb/article-pdf/61/1/158/35016256/bbb0158.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1271/bbb.61.158?email=unpaywall_01@example.com

published in

Bioscience, Biotechnology, and Biochemistry

1 reference

16 August 2017

61

1 reference

16 August 2017

158-159

1 reference

16 August 2017

1

1 reference

https://api.unpaywall.org/v2/10.1271/bbb.61.158?email=unpaywall_01@example.com

16 August 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

BE-14348 substances, new specific estrogen-receptor binding inhibitors. Production, isolation, structure determination and biological properties

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.1533

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Antioxidative activity of hop bitter acids and their analogues

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.59.740

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Is oestrogenic activity present in hops?

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

A modified demonstration reaction for estrogen on paper and thin layer chromatography

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Establishment of a rapid bone resorption in vitro assay using previously frozen mouse unfractionated bone cells pretreated with parathyroid hormone

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Evidence that c-src is involved in the process of osteoclastic bone resorption

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

The role of reactive oxygen intermediates in osteoclastic bone resorption

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1271/BBB.61.158

Identifiers

DOI

10.1271/BBB.61.158

1 reference

16 August 2017

1 reference